These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 3735085)

  • 1. Application of a radiotelemetric system to evaluate the performance of enteric coated and plain aspirin tablets.
    Lui CY; Oberle R; Fleisher D; Amidon GL
    J Pharm Sci; 1986 May; 75(5):469-74. PubMed ID: 3735085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption of acetylsalicylic acid from enteric-coated tablets in relation to gastric emptying and in-vivo disintegration.
    Bogentoft C; Alpsten M; Ekenved G
    J Pharm Pharmacol; 1984 May; 36(5):350-1. PubMed ID: 6145780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
    Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of enteric coating of aspirin tablets on occult gastrointestinal blood loss.
    Howe GB; Champion GD; Corrigan AB; Hewson J; Haski A; Day RO; Paull PD; Graham GG
    Aust N Z J Med; 1977 Dec; 7(6):600-4. PubMed ID: 350214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analgesics; the use of aspirin in dogs; effects of tablet type and food intake on plasma salicylate level].
    Nap RC; Breen DJ; Lam TJ; Peters IO; Willemsen A; De Bruyne JJ
    Tijdschr Diergeneeskd; 1993 Jul; 118(13):439-42. PubMed ID: 8346511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotelemetric method for evaluating enteric coatings in vivo.
    Dressman JB; Amidon GL
    J Pharm Sci; 1984 Jul; 73(7):935-8. PubMed ID: 6470956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylsalicylic acid metabolites in blood and urine after plain and enteric-coated tablets.
    Montgomery PR; Sitar DS
    Biopharm Drug Dispos; 1986; 7(1):21-5. PubMed ID: 3955197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an enteric coated aspirin preparation.
    Day RO; Paull PD; Champion GD; Graham GG
    Aust N Z J Med; 1976 Feb; 6(1):45-50. PubMed ID: 1065299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of food on the absorption of enteric-coated aspirin: correlation with gastric residence time.
    Mojaverian P; Rocci ML; Conner DP; Abrams WB; Vlasses PH
    Clin Pharmacol Ther; 1987 Jan; 41(1):11-7. PubMed ID: 3802700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward Biopredictive Dissolution for Enteric Coated Dosage Forms.
    Al-Gousous J; Amidon GL; Langguth P
    Mol Pharm; 2016 Jun; 13(6):1927-36. PubMed ID: 27139040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability.
    Portek I; Graham G; Fleming A
    Med J Aust; 1981 Jul; 2(1):39-40. PubMed ID: 6974303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric retention of enteric-coated aspirin tablets in beagle dogs.
    Nap RC; Breen DJ; Lam TJ; De Bruyne JJ
    J Vet Pharmacol Ther; 1990 Jun; 13(2):148-53. PubMed ID: 2384905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of formulation of enteric coated tablets on the bioavailability of the drug. 4th Part: Influence of the enteric polymer dissolution pH on the "in vivo" absorption of aspirin from coated tablets (author's transl)].
    Delporte JP; Jaminet F
    J Pharm Belg; 1976; 31(3):263-76. PubMed ID: 8603
    [No Abstract]   [Full Text] [Related]  

  • 15. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.
    Hosny EA; el-Mahrouk GM; Gouda MW
    Drug Dev Ind Pharm; 1998 Jul; 24(7):661-6. PubMed ID: 9876511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of food on the absorption of acetylsalicylic acid from enteric-coated dosage forms.
    Bogentoft C; Carlsson I; Ekenved G; Magnusson A
    Eur J Clin Pharmacol; 1978 Dec; 14(5):351-5. PubMed ID: 32046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric emptying rates of drug preparations. II. Effects of size and density of enteric-coated drug preparations and food on gastric emptying rates in humans.
    Kaniwa N; Aoyagi N; Ogata H; Ejima A; Motoyama H; Yasumi H
    J Pharmacobiodyn; 1988 Aug; 11(8):571-5. PubMed ID: 3236215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.
    Miner PB; Fort JG; Zhang Y
    Aliment Pharmacol Ther; 2013 Jul; 38(1):62-71. PubMed ID: 23692061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric emptying and absorption of acetylsalicylic acid administered as enteric-coated micro-granules.
    Alpsten M; Bogentoft C; Ekenved G; Sölvell L
    Eur J Clin Pharmacol; 1982; 22(1):57-61. PubMed ID: 7094976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of omeprazole with enteric-coated salicylate tablets.
    Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.